Table of Contents:
  • Contents: US regulation of cell and gene therapies
  • Gene therapies
  • Cell-engineering
  • Cell therapy
  • Advanced therapies medicinal products (ATMP)
  • Definition and classification of cell and gene therapies
  • Drug regulatory affairs
  • Biological drugs
  • Drug development
  • Clinical development
  • Pre-IND meetings
  • BLA review
  • Special Protocol Assessment (SPA)
  • Fast track, breakthrough and RMAT Designation